APO RESEARCH · REPORT
Chitosan Derivatives
Chitosan is a linear polysaccharide composed of randomly distributed β-(1-4)-linked D-glucosamine and N-acetyl-D-glucosamine. It is produced by basic (caustic soda) deacetylation reaction of chitin, the main component of fungi cell walls and insect or crustacean exoskeletons.
Product & engineering
Understand the product.
Chitosan is a linear polysaccharide composed of randomly distributed β-(1-4)-linked D-glucosamine and N-acetyl-D-glucosamine. It is produced by basic (caustic soda) deacetylation reaction of chitin, the main component of fungi cell walls and insect or crustacean exoskeletons.
Selected research
Industry Growth & Trends
Global Chitosan Derivatives Industry Growth and Trends Forecast to 2032
Market perspective
Chitosan is a linear polysaccharide composed of randomly distributed β-(1-4)-linked D-glucosamine and N-acetyl-D-glucosamine. It is produced by basic (caustic soda) deacetylation reaction of chitin, the main component of fungi cell walls and insect or crustacean exoskeletons.
The major players in global Chitosan Derivatives market include Golden-Shell, Lushen Bioengineering, AK BIOTECH, etc. The top 3 players occupy about 30% shares of the global market. China is the main market, and occupies about 50% of the global market. Chitosan HCl is the main type, with a share about 45%. Medical is the main application, which holds a share about 40%.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Chitosan Derivatives market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Chitosan Derivatives market size, estimates, and forecasts are presented in terms of sales volume (MT) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Chitosan Derivatives market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Chitosan Derivatives.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Chitosan Derivatives market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Chitosan Derivatives Market by Company
FMC Corp
Kitozyme
Kunpoong Bio
BIO21
Heppe Medical Chitosan
Yaizu Suisankagaku
Golden-Shell
Lushen Bioengineering
AK BIOTECH
Zhejiang New Fuda Ocean Biotech
Weifang Sea Source Biological Products
Qingdao Honghai Bio-tech
Haidebei Marine Bioengineering
Jiangsu Aoxin Biotechnology
Jinhu Crust Product
Chitosan Derivatives Segment by Type
Chitosan HCl
Carboxymethyl Chitosan
Chitosan Quaternary Ammonium Salt
Hydroxypropyl Chitosan
Chitosan Oligosaccharide
Others
Chitosan Derivatives Segment by Application
Medical
Health Food
Cosmetics
Water Treatment
Others
Chitosan Derivatives Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chitosan Derivatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chitosan Derivatives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chitosan Derivatives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chitosan Derivatives manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Chitosan Derivatives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Chitosan HCl
- Carboxymethyl Chitosan
- Chitosan Quaternary Ammonium Salt
- Hydroxypropyl Chitosan
- Chitosan Oligosaccharide
- Others
Applications
- Medical
- Health Food
- Cosmetics
- Water Treatment
- Others
Companies covered
- FMC Corp
- Kitozyme
- Kunpoong Bio
- BIO21
- Heppe Medical Chitosan
- Yaizu Suisankagaku
- Golden-Shell
- Lushen Bioengineering
- AK BIOTECH
- Zhejiang New Fuda Ocean Biotech
- Weifang Sea Source Biological Products
- Qingdao Honghai Bio-tech
- Haidebei Marine Bioengineering
- Jiangsu Aoxin Biotechnology
- Jinhu Crust Product
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Chitosan Derivatives Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Chitosan Derivatives Sales Estimates and Forecasts (2021-2032)
- 1.3 Chitosan Derivatives Market by Type
- 1.3.1 Chitosan HCl
- 1.3.2 Carboxymethyl Chitosan
- 1.3.3 Chitosan Quaternary Ammonium Salt
- 1.3.4 Hydroxypropyl Chitosan
- 1.3.5 Chitosan Oligosaccharide
- 1.3.6 Others
- 1.4 Global Chitosan Derivatives Market Size by Type
- 1.4.1 Global Chitosan Derivatives Market Size Overview by Type (2021-2032)
- 1.4.2 Global Chitosan Derivatives Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Chitosan Derivatives Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Chitosan Derivatives Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Chitosan Derivatives Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Chitosan Derivatives Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Chitosan Derivatives Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Chitosan Derivatives Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Chitosan Derivatives Industry Trends
- 2.2 Chitosan Derivatives Industry Drivers
- 2.3 Chitosan Derivatives Industry Opportunities and Challenges
- 2.4 Chitosan Derivatives Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Chitosan Derivatives Revenue (2021-2026)
- 3.2 Global Top Players by Chitosan Derivatives Sales (2021-2026)
- 3.3 Global Top Players by Chitosan Derivatives Price (2021-2026)
- 3.4 Global Chitosan Derivatives Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Chitosan Derivatives Major Company Production Sites & Headquarters
- 3.6 Global Chitosan Derivatives Company, Product Type & Application
- 3.7 Global Chitosan Derivatives Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Chitosan Derivatives Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Chitosan Derivatives Players Market Share by Revenue in 2025
- 3.8.3 2025 Chitosan Derivatives Tier 1, Tier 2, and Tier 3
4 Chitosan Derivatives Regional Status and Outlook
- 4.1 Global Chitosan Derivatives Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Chitosan Derivatives Historic Market Size by Region
- 4.2.1 Global Chitosan Derivatives Sales in Volume by Region (2021-2026)
- 4.2.2 Global Chitosan Derivatives Sales in Value by Region (2021-2026)
- 4.2.3 Global Chitosan Derivatives Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Chitosan Derivatives Forecasted Market Size by Region
- 4.3.1 Global Chitosan Derivatives Sales in Volume by Region (2027-2032)
- 4.3.2 Global Chitosan Derivatives Sales in Value by Region (2027-2032)
- 4.3.3 Global Chitosan Derivatives Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Chitosan Derivatives by Application
- 5.1 Chitosan Derivatives Market by Application
- 5.1.1 Medical
- 5.1.2 Health Food
- 5.1.3 Cosmetics
- 5.1.4 Water Treatment
- 5.1.5 Others
- 5.2 Global Chitosan Derivatives Market Size by Application
- 5.2.1 Global Chitosan Derivatives Market Size Overview by Application (2021-2032)
- 5.2.2 Global Chitosan Derivatives Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Chitosan Derivatives Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Chitosan Derivatives Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Chitosan Derivatives Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Chitosan Derivatives Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Chitosan Derivatives Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Chitosan Derivatives Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 FMC Corp
- 6.1.1 FMC Corp Company Information
- 6.1.2 FMC Corp Business Overview
- 6.1.3 FMC Corp Chitosan Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 FMC Corp Chitosan Derivatives Product Portfolio
- 6.1.5 FMC Corp Recent Developments
- 6.2 Kitozyme
- 6.2.1 Kitozyme Company Information
- 6.2.2 Kitozyme Business Overview
- 6.2.3 Kitozyme Chitosan Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Kitozyme Chitosan Derivatives Product Portfolio
- 6.2.5 Kitozyme Recent Developments
- 6.3 Kunpoong Bio
- 6.3.1 Kunpoong Bio Company Information
- 6.3.2 Kunpoong Bio Business Overview
- 6.3.3 Kunpoong Bio Chitosan Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Kunpoong Bio Chitosan Derivatives Product Portfolio
- 6.3.5 Kunpoong Bio Recent Developments
- 6.4 BIO21
- 6.4.1 BIO21 Company Information
- 6.4.2 BIO21 Business Overview
- 6.4.3 BIO21 Chitosan Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 BIO21 Chitosan Derivatives Product Portfolio
- 6.4.5 BIO21 Recent Developments
- 6.5 Heppe Medical Chitosan
- 6.5.1 Heppe Medical Chitosan Company Information
- 6.5.2 Heppe Medical Chitosan Business Overview
- 6.5.3 Heppe Medical Chitosan Chitosan Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Heppe Medical Chitosan Chitosan Derivatives Product Portfolio
- 6.5.5 Heppe Medical Chitosan Recent Developments
- 6.6 Yaizu Suisankagaku
- 6.6.1 Yaizu Suisankagaku Company Information
- 6.6.2 Yaizu Suisankagaku Business Overview
- 6.6.3 Yaizu Suisankagaku Chitosan Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Yaizu Suisankagaku Chitosan Derivatives Product Portfolio
- 6.6.5 Yaizu Suisankagaku Recent Developments
- 6.7 Golden-Shell
- 6.7.1 Golden-Shell Company Information
- 6.7.2 Golden-Shell Business Overview
- 6.7.3 Golden-Shell Chitosan Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Golden-Shell Chitosan Derivatives Product Portfolio
- 6.7.5 Golden-Shell Recent Developments
- 6.8 Lushen Bioengineering
- 6.8.1 Lushen Bioengineering Company Information
- 6.8.2 Lushen Bioengineering Business Overview
- 6.8.3 Lushen Bioengineering Chitosan Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Lushen Bioengineering Chitosan Derivatives Product Portfolio
- 6.8.5 Lushen Bioengineering Recent Developments
- 6.9 AK BIOTECH
- 6.9.1 AK BIOTECH Company Information
- 6.9.2 AK BIOTECH Business Overview
- 6.9.3 AK BIOTECH Chitosan Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 AK BIOTECH Chitosan Derivatives Product Portfolio
- 6.9.5 AK BIOTECH Recent Developments
- 6.10 Zhejiang New Fuda Ocean Biotech
- 6.10.1 Zhejiang New Fuda Ocean Biotech Company Information
- 6.10.2 Zhejiang New Fuda Ocean Biotech Business Overview
- 6.10.3 Zhejiang New Fuda Ocean Biotech Chitosan Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Zhejiang New Fuda Ocean Biotech Chitosan Derivatives Product Portfolio
- 6.10.5 Zhejiang New Fuda Ocean Biotech Recent Developments
- 6.11 Weifang Sea Source Biological Products
- 6.11.1 Weifang Sea Source Biological Products Company Information
- 6.11.2 Weifang Sea Source Biological Products Business Overview
- 6.11.3 Weifang Sea Source Biological Products Chitosan Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Weifang Sea Source Biological Products Chitosan Derivatives Product Portfolio
- 6.11.5 Weifang Sea Source Biological Products Recent Developments
- 6.12 Qingdao Honghai Bio-tech
- 6.12.1 Qingdao Honghai Bio-tech Company Information
- 6.12.2 Qingdao Honghai Bio-tech Business Overview
- 6.12.3 Qingdao Honghai Bio-tech Chitosan Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Qingdao Honghai Bio-tech Chitosan Derivatives Product Portfolio
- 6.12.5 Qingdao Honghai Bio-tech Recent Developments
- 6.13 Haidebei Marine Bioengineering
- 6.13.1 Haidebei Marine Bioengineering Company Information
- 6.13.2 Haidebei Marine Bioengineering Business Overview
- 6.13.3 Haidebei Marine Bioengineering Chitosan Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Haidebei Marine Bioengineering Chitosan Derivatives Product Portfolio
- 6.13.5 Haidebei Marine Bioengineering Recent Developments
- 6.14 Jiangsu Aoxin Biotechnology
- 6.14.1 Jiangsu Aoxin Biotechnology Company Information
- 6.14.2 Jiangsu Aoxin Biotechnology Business Overview
- 6.14.3 Jiangsu Aoxin Biotechnology Chitosan Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Jiangsu Aoxin Biotechnology Chitosan Derivatives Product Portfolio
- 6.14.5 Jiangsu Aoxin Biotechnology Recent Developments
- 6.15 Jinhu Crust Product
- 6.15.1 Jinhu Crust Product Company Information
- 6.15.2 Jinhu Crust Product Business Overview
- 6.15.3 Jinhu Crust Product Chitosan Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Jinhu Crust Product Chitosan Derivatives Product Portfolio
- 6.15.5 Jinhu Crust Product Recent Developments
7 North America by Country
- 7.1 North America Chitosan Derivatives Sales by Country
- 7.1.1 North America Chitosan Derivatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Chitosan Derivatives Sales by Country (2021-2026)
- 7.1.3 North America Chitosan Derivatives Sales Forecast by Country (2027-2032)
- 7.2 North America Chitosan Derivatives Market Size by Country
- 7.2.1 North America Chitosan Derivatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Chitosan Derivatives Market Size by Country (2021-2026)
- 7.2.3 North America Chitosan Derivatives Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Chitosan Derivatives Sales by Country
- 8.1.1 Europe Chitosan Derivatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Chitosan Derivatives Sales by Country (2021-2026)
- 8.1.3 Europe Chitosan Derivatives Sales Forecast by Country (2027-2032)
- 8.2 Europe Chitosan Derivatives Market Size by Country
- 8.2.1 Europe Chitosan Derivatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Chitosan Derivatives Market Size by Country (2021-2026)
- 8.2.3 Europe Chitosan Derivatives Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Chitosan Derivatives Sales by Country
- 9.1.1 Asia-Pacific Chitosan Derivatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Chitosan Derivatives Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Chitosan Derivatives Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Chitosan Derivatives Market Size by Country
- 9.2.1 Asia-Pacific Chitosan Derivatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Chitosan Derivatives Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Chitosan Derivatives Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Chitosan Derivatives Sales by Country
- 10.1.1 South America Chitosan Derivatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Chitosan Derivatives Sales by Country (2021-2026)
- 10.1.3 South America Chitosan Derivatives Sales Forecast by Country (2027-2032)
- 10.2 South America Chitosan Derivatives Market Size by Country
- 10.2.1 South America Chitosan Derivatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Chitosan Derivatives Market Size by Country (2021-2026)
- 10.2.3 South America Chitosan Derivatives Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Chitosan Derivatives Sales by Country
- 11.1.1 Middle East and Africa Chitosan Derivatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Chitosan Derivatives Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Chitosan Derivatives Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Chitosan Derivatives Market Size by Country
- 11.2.1 Middle East and Africa Chitosan Derivatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Chitosan Derivatives Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Chitosan Derivatives Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Chitosan Derivatives Value Chain Analysis
- 12.1.1 Chitosan Derivatives Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Chitosan Derivatives Production Mode & Process
- 12.2 Chitosan Derivatives Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Chitosan Derivatives Distributors
- 12.2.3 Chitosan Derivatives Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst